Aligos Therapeutics

This early-stage trial tests an experimental oral drug called ALG-000184 in healthy volunteers and people with chronic hepatitis B. The main goals are to check safety, how the body processes the drug, and whether it can lower hepatitis B virus levels. Participants take the drug d…

This early-stage study looked at how the experimental drug ALG-097558 behaves in 16 people with moderate liver impairment compared to healthy volunteers. The goal was to measure drug levels and safety, not to treat COVID-19. Results will help guide future dosing for patients with…

This early study tests how the experimental COVID-19 drug ALG-097558 moves through the body in people with severe kidney problems compared to healthy volunteers. Twelve adults will take multiple doses of the drug. The goal is to see if kidney function affects drug levels and safe…